1
Clinical Trials associated with Universal NK cell(Jiangsu Provincial People's Hospital) / Not yet recruitingEarly Phase 1IIT Early Clinical Study of JY306 Universal NK Cell Injection in the Treatment of Adult Relapsed or Refractory CD70+ Malignant Hematologic Tumors
1. Primary objectives of study:To valuate the tolerability and safety of JY306 in patients with relapsed or refractory CD70 + malignant hematological tumors.
2. Secondary objectives of study:To conduct a preliminary Evaluation of the Efficacy, Pharmacokinetics, and Pharmacodynamics of JY306 in Patients with Relapsed or Refractory CD70+ Malignant Hematological Tumors.
100 Clinical Results associated with Universal NK cell(Jiangsu Provincial People's Hospital)
100 Translational Medicine associated with Universal NK cell(Jiangsu Provincial People's Hospital)
100 Patents (Medical) associated with Universal NK cell(Jiangsu Provincial People's Hospital)
100 Deals associated with Universal NK cell(Jiangsu Provincial People's Hospital)